Clinical trials show significant reduction in COPD flare-ups with investigational therapy

Two planetary objective trials led successful portion by researchers astatine the University of Pittsburgh School of Medicine recovered that the investigational biologic therapy tozorakimab importantly reduced chronic obstructive pulmonary illness (COPD) flare-ups among patients already receiving modular attraction for the illness compared with patients receiving lone modular treatment. The findings are published contiguous successful the New England Journal of Medicine.